Search

everythinglearnresearchcommunity

for

Search:↓

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

AMP-303 safely increases hair growth in men with hair loss.

A parasite molecule can speed up skin healing and reduce scarring.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Abatacept may help some people with alopecia areata regrow hair.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

RC48 shows promise for treating certain advanced cancers, but more research is needed.